Biotech Press Releases

As a preclinical contract research provider dedicated to offering comprehensive research services, Ace Therapeutics provides a complete one-stop service for developing custom animal models to support preclinical psychiatry research.

Rising demand for biopharmaceuticals, investments in genetic engineering, and medical R&D for vaccines & biologics are expected to drive growth in the protein engineering market.

NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP): License and Distribution Terms Set for Lucrative Suicide Depression Treatment; $31 Price Target from Respected Investment Analyst D. Boral Capital

Premier Dental Implant Center Dentaluxe Unveils Cutting-Edge New Website to Enhance Patient Experience in Jacksonville, Florida

$NRXP is Poised to Address the $3 Billion + Suicidal Depression Market in the US

Matt Hagan Named Vice President of Marketing and Client Innovation

Discover the Essence of Nature with Aravi Organic's New Website

Restoration Dental has launched a new website with enhanced features designed for patient convenience and education as part of its commitment to patient-centered care.

OneSolution Dental Implant Centers is hosting the All-on-X Digital Workflow Master Course, a premier two-day training program for dental professionals seeking to master advanced digital techniques in full-arch implant restorations.

The scientific instrument company is honored to be chosen as one of 12 innovative companies to help U.S. companies expand into international markets and connect with key partners at Singapore Maritime week and Sea Asia March 23-29th 2025.

Inavya Ventures Ltd Recognized Among the Most Innovative Companies to Watch in 2025 by The CEO Vision The CEO Vision, a premier business magazine dedicated to recognizing trailblazing companies and leaders, proudly names Inavya Ventures Ltd as one of the.

Our Goal Is To Bring Awareness to Business Owners On Employment Taxes And How To Minimize Them

$RENB Secures $15 Million in New Equity to Support Operations Towards Revolutionizing Healthcare with $POAI

Exploring Virtual Reality in Healthcare: GRT Institute of Engineering & Technology students gain hands-on experience at WHY Global Services through an industry visit focused on innovation and career insights.

$RENB Collaboration with $NVDA to Employ NVIDIA AI Tech with Established GEDi CUBE as a Paradigm Shift for Early Disease Detection

Arsenale Bioyards a neo-industrial company fundamentally redefining scalable biomanufacturing, has announced the successful closure of its first $10 million seed financing round.

NEXS BioMedica, a forward-thinking biotech pharmaceutical company, proudly introduces CancerScope-AI, an innovative artificial intelligence system set to transform the battle against rare cancers.

NeuroZenn is now available for all Veterans to have prescribed for nerve pain at all veteran Affairs Hospitals.

Comprehensive insights into market growth, breakthrough innovations, funding trends, and intellectual property shaping the future of synthetic biology.

As per DPI Research's latest published report, the Australia Non-Invasive Prenatal Testing (NIPT) market size was valued at USD 57.8 million in 2024 and is projected to hit around USD 83.3 million by 2033, growing at a CAGR of 4.1%

Pharma groups play a essential function in clinical services, ensuring that medicines attain individuals who need them.

In the fast-moving biotechnology world, where speed and precision are key, Creative Biolabs is making waves with its high throughput antibody production services.

Biovenic, a powerhouse in veterinary research, transforms the way to detect and manage animal diseases.

Sano Women's Health has received investigational new drug approval from the FDA, for Occidiofungin, a first-in-class novel peptide with broad antifungal activity.

Curtana Pharmaceuticals, a biotechnology company focused on improving outcomes for brain cancer patients, is proud to announce the publication of two pioneering studies in Nature Communications.

The global CT scanner market was valued at USD 6.94 billion in 2024 and is projected to grow at a CAGR of 6.8% from 2025 to 2032, reaching an estimated value of USD 11.75 billion by the end of the forecast period.

Manhattan BioSolutions, Inc. ("MABS"), an emerging biotechnology company developing new classes of precision biologics that harness natural host defense mechanisms, today announced that its RNA-targeting therapeutic, MABS-139, will be evaluated in...

Disrupting the healthcare consulting landscape, Improzo Inc. is rapidly gaining traction with its innovative approach that tackles modern challenges and prioritizes patients.

Oak Therapeutics, a pioneering early-stage life sciences company, announces the successful development of an innovative Oral Dissolvable Strip (ODS) formulation for the treatment of HIV/AIDS in infants and young children.

$NRXP given a $31 Price Target from Respected Investment Analyst D. Boral Capital

Five leaders honored as champions of small business and non-profit ecosystems